StockData
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30

NANOVIRICIDES, INC.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.30−0.08 (-5.80%)

Close on Oct 19, 2026

Market cap
$28.93M
P/E (TTM)
–
Dividend yield
–

NANOVIRICIDES, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Nanoviricides does not break out revenue by segment, region or product in the tagged data of its filings for this period type.